Kelly J. Larson

Diacylglycerol Acyltransferase 1 Inhibition Lowers Serum Triglycerides in the Zucker Fatty Rat and the Hyperlipidemic Hamster

Andrew King, Jason A. Segreti, Kelly J. Larson et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 57 citations

Life Sciences, Biochemistry, Pharmacology +17

Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P₅) Agonist for the Potential Treatment of Neurodegenerative Disorders

Adrian D. Hobson, Christopher M. Harris, Elizabeth L. van der Kam et al. · Journal of Medicinal Chemistry · 2015 · 48 citations · Full text

Medicine, Neuroscience, Pharmacology +17

In vivo efficacy of acyl CoA: Diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia

Andrew King, Jason A. Segreti, Kelly J. Larson et al. · European Journal of Pharmacology · 2010 · 37 citations

Life Sciences, Biochemistry, Pharmacology +16

Identification and Preliminary Characterization of a Potent, Safe, and Orally Efficacious Inhibitor of Acyl-CoA:Diacylglycerol Acyltransferase 1

Vince S. C. Yeh, David W. A. Beno, Sevan Brodjian et al. · Journal of Medicinal Chemistry · 2012 · 34 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure models

Marcin Klapczynski, Gerard D. Gagné, Sherry J. Morgan et al. · Journal of Pathology Informatics · 2012 · 34 citations · Full text

Medicine, Nephrology, Pathology +16